National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.MMWR Recomm Rep2009; 58: 1–8.
2.
MarcelliD., MarelliC., RichardsN.Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey.Nephrol Dial Transplant2009; 24: 3566–72.
3.
FriedL., BernardiniJ., PirainoB.Comparison of the Charlson comorbidity index and the Davies score as a predictor of outcomes in PD patients.Perit Dial Int2003; 23: 568–73.
4.
LeeD.H., ShinS.S., JunB.Y., LeeJ.K.National level response to pandemic (H1N1) 2009 [Korean].J Prev Med Public Health2010; 43: 99–104.
5.
HancockK., VeguillaV., LuX., ZhongW., ButlerE.N., SunHCross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.N Engl J Med2009; 361: 1945–52.
6.
ZarychanskiR., StuartT.L., KumarA., DoucetteS., ElliottL., KettnerJ.Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection.CMAJ2010; 182: 257–64.
7.
CampbellA., RodinR., KroppR., MaoY., HongZ., VachonJ.Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza.CMAJ2010; 182: 349–55.
8.
ChowellG., BertozziS.M., ColcheroM.A., Lopez-GatellH., Alpuche-ArandaC., HernandezM.Severe respiratory disease concurrent with the circulation of H1N1 influenza.N Engl J Med2009; 361: 674–9.
9.
MillerM.A., ViboudC., BalinskaM., SimonsenL.The signature features of influenza pandemics—implications for policy.N Engl J Med2009; 360: 2595–8.
